CAR T Immunotherapy
Novel allogeneic chimeric antigen receptor (CAR) T cell
therapies for treating cancer.
In Vivo Gene Editing
In vivo gene editing therapies to permanently
correct genetic diseases.
Dedicated to Improving Life
At Precision BioSciences we are ‘Dedicated to Improving Life’ and are using our novel ARCUS genome editing technology to develop a new class of medicines designed to overcome and potentially cure, hard-to-treat conditions including cancer and genetic diseases.
ARCUS Genome Editing
ARCUS is a precise and versatile genome editing technology discovered and developed by scientists at Precision BioSciences. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases to insert (knock in), remove (knock out), or repair DNA of living cells and tissues.